Associate Vice President-Clinical Design Scientist-Neuroscience and Pain

Indianapolis, IN, United States

At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world.

Clinical Design Scientist – Clinical Design

Purpose

Clinical Design provides clinical program and trial design leadership and expertise within Eli Lilly – designing novel clinical programs to answer scientific questions, align with the corporate and asset strategies, and enable delivery. The value proposition is achieved by applying design excellence competencies and principles related to value-based research, data-driven decisions, and accelerated delivery. Clinical Design leverages internal and external information within and across therapeutic areas to provide modern, innovative solutions to Lilly’s drug development needs.

The purpose of the Clinical Design Scientist is to provide Medical and scientific leadership in the clinical program and trial design of assets approaching and/or primarily in Phases II to IV. In order to accomplish this, the Clinical Design Scientist must have a deep understanding of the biopharmaceutical industry, drug development process, the therapeutic area that is relevant for the programs in development, clinical research, and clinical program and study design. Thus, the Clinical Design Scientist provides scientific, clinical, and therapeutic expertise/application, and leadership in the creation of program and trial designs that can be executed.

The Clinical Design Scientist may be called upon to participate on additional items including but not limited to protocols, publications, regulatory interactions, internal executive and governance presentations, external key opinion leader interactions, medical outreach/advocacy, and industry conferences.

Primary Responsibilities

The primary responsibilities of the Clinical Design Scientist are focused on the design of Phase II to Phase IV clinical programs and studies within the therapeutic area. The core job responsibilities typically include those listed below as well as all other duties as assigned.

Clinical Plan Options and Clinical Trial Protocols

As the Medical leader on a cross-functional Clinical Design team, translate therapeutic area and asset team strategy into clear objectives and associated clinical development program and trial optionality. Optionality will address business and customer needs (patient, prescriber, payer, and/or regulator); be in alignment with phase of product lifecycle; and clearly articulate associated tradeoffs in value (data generated, risks created/discharged, cost, and time).

Represent program and trial design optionality to asset teams and Sr. Leaders to inform prioritization of an option that will be translated into a clinical protocol(s). Adjust optionality in accordance with feedback from leadership.

Bring the medical/clinical perspective to the Design Team to inform the design of study protocols and in partnership with the other functions (e.g. Asset Team, BU Development Team).

Provide insight into impact of study/protocol design features to feasibility, value, patient and investigator burden, and execution speed/efficiency.

Contribute to the development of asset strategy (e.g., identification of target patient population) in partnership with the asset team.

Contribute to business unit and global alignment of portfolio clinical strategy and the associated asset-specific clinical plans including main indication and line extensions.

.

Clinical Research/Trial Packages, Execution and Support

Collaborate and complement clinical research staff in the design and conduct of clinical trials (e.g. sample size, patient commitment, timelines, grants, and governance review interactions).

Understand how design elements influence the ability to deliver on new regulatory expectations (e.g. decentralization of clinical trials, increase racial and ethnic diversity in clinical trials) and clinical capabilities (e.g. value-based, patient accessibility, patient burden).

Review risk profiles to ensure appropriate communication of risk to study subjects via the protocol.

Support investigator identification and selection, in conjunction with Clinical Development.

Partner with Clinical Development to accelerate participant recruitment and retention efforts – especially considering how design elements can create value in these areas.

Support seamless transition of protocols from design to execution.

Scientific Data Dissemination/Exchange

Knowledge of and compliance with local laws and regulations, global policies and procedures, and compliance guidelines with respect to data dissemination and interactions with external health care professionals.

Establish and maintain appropriate collaborations and relationships with external experts, thought leaders, and the general medical community.

Develop and maintain appropriate collaborations and relationships with relevant professional societies, conferences, and consortia.

Participate in development of scientific data dissemination and preparation of final reports and publications related to assets and/or support efforts to influence clinical design science within the industry.

Scientific / Technical Expertise

Critically read, evaluate, and apply the relevant medical literature, status and data from competitive products, and updates with medical and other scientific developments relevant to the therapeutic area, disease state, and product.

Be aware of current trends and projections for clinical research, practice, and access in the therapeutic area(s) relevant to the product.

Engage appropriately with the asset teams and the business unit development teams on relevant external activities to have good understanding of their patients, medical and payer communities, and business strategy.

Apply the above to the optionality recommended for clinical programs and trials and when supporting other medical-related areas as assigned.

Shared Learning

Focus on organizational learning to proactively identify, apply, and share best practices and learnings related to program and protocol design within and outside the organization.

Closely collaborate with asset teams and delivery teams to understand the impact of design on speed to protocol approval and study startup. Identify and participate in opportunities to analyze experience and improve approaches.

Work closely with counterparts in Clinical Design and therapeutic areas to continue to evolve Lilly standards, tools, and best practices that span drug development.

Provide clinical leadership in collaboration with other Clinical Design members in appropriate development of standardized/simplified processes, templates, and tools.

Minimum Qualification Requirements:

A relevant, advanced health/medical/scientific degree, Or

a related, relevant graduate degree such as DVM, PharmD, PhD, or MSN with advanced clinical specialty (Clinical Nurse Specialist, Nurse Practitioner)

and

Pharmaceutical Industry experience, or similar, of at least three (3) years that provides adequate background relevant to clinical trial design of PhII to Phase IV studies (e.g., designing clinical programs, trials, and/or protocols, statistical/inferential methods, rating instruments, regulatory standards, safety assessment, investigator/site management, decentralized clinical trials).

Strong communication skills across diverse platforms and stakeholders; adept at influencing and aligning teams to advance business strategies while utilizing interpersonal, organizational, teamwork and negotiation skills.

OR

4-year bachelor’s or master’s degree in a health/medical/scientific discipline

and

Pharmaceutical Industry experience, or similar, of at least seven (7) years that provides adequate background relevant to clinical trial design of PhII to Phase IV studies (e.g., designing clinical programs, trials, and/or protocols, statistical/inferential methods, rating instruments, regulatory standards, safety assessment, investigator/site management, decentralized clinical trials).

Strong communication skills across diverse platforms and stakeholders; adept at influencing and aligning teams to advance business strategies while utilizing interpersonal, organizational, teamwork and negotiation skills.

Additional Preferences:

Clinical research experience in the therapeutic area

Strong understanding of therapeutic area pathology, pathophysiology, unmet needs, and treatment standards in major geographies (e.g. US, EU, Japan, China, etc).

Strong foundation in statistical science, including Bayesian statistics, as applied to study design (e.g., sample size determination, setting of critical success factors). Ability to communicate effectively with statisticians and help translate complex principles to inform design optionality and protocols.

Global / multi-national design or development experience

MBA or similarly relevant training.

Willing to relocate to Indianapolis. If unable to relocate, demonstrated ability to work with high effectiveness from a remote location in a hybrid environment. Willing to travel for business-critical events and to develop a strong internal network.

Willing to engage in limited domestic and international travel to the degree appropriate to support the business of the team.

Fluent in English, with strong communication skills, verbal and written.

Strong interpersonal, organizational, and negotiation skills.

Ability to influence others (both cross-functionally and within the function) to advance objectives.

Understanding of how design elements translate into delivery. Bias for simplifying, reducing burden, and creation of value through excellent design.

Strong communication skills demonstrated in a variety of modalities (e.g. presentations, meetings, creation of protocols and regulatory documents) and with broad set of stakeholders (e.g. team leaders, Sr. Leader decision makers, medical and non-medical counterparts, thought leaders, investigators, regulators).

OTHER INFORMATION

Primary internal interactions

Clinical Design and Development teammates and leadership

Clinical planning, clinical capabilities, and other research staff

Team leaders and COOs

Sr. Leaders within Clinical, R&D, therapeutic areas, and business units

Statisticians

Scientific communication associates

Health outcomes research consultants/research scientists

Regulatory directors, scientists, and associates

Product directors, managers, and associates of the brand teams

Legal counsel

Therapeutic area physicians, development CRP/Ss, medical affairs CRP/Ss, early phase physicians, and Sr. Medical leaders

Pricing, Access, and Reimbursement

New Product Planning

Global Marketing director or manager

Global patient safety

External Contacts

Scientific and clinical experts, thought leaders

Lilly clinical investigators

Practicing physicians/prescribers

Regulatory agency personnel

Professional association staff and leaders

Disease advocates and lay organizations focused on relevant health issues

Formulary representatives (private and government)

Eli Lilly and Company, Lilly USA, LLC and our wholly owned subsidiaries (collectively “Lilly”) are committed to help individuals with disabilities to participate in the workforce and ensure equal opportunity to compete for jobs. If you require an accommodation to submit a resume for positions at Lilly, please email Lilly Human Resources ( [email protected] ) for further assistance. Please note This email address is intended for use only to request an accommodation as part of the application process. Any other correspondence will not receive a response.

Lilly is an EEO/Affirmative Action Employer and does not discriminate on the basis of age, race, color, religion, gender, sexual orientation, gender identity, gender expression, national origin, protected veteran status, disability or any other legally protected status.

Our employee resource groups (ERGs) offer strong support networks for their members and help our company develop talented individuals for future leadership roles. Our current groups include: Africa, Middle East, Central Asia Network, African American Network, Chinese Culture Network, Early Career Professionals, Japanese International Leadership Network (JILN), Lilly India Network, Organization of Latinos at Lilly, PRIDE (LGBTQ + Allies), Veterans Leadership Network, Women’s Network, Working and Living with Disabilities. Learn more about all of our groups.

#WeAreLilly

#J-18808-Ljbffr